Management of atrial fibrillation in Russia: real clinical practice and current clinical guidelines
https://doi.org/10.35336/VA-2021-2-55-63
Abstract
Results of the survey which conducted with specialists who involved in the treatment of patients with atrial fibrillation regarding treatment strategy, choice of antiarrhythmic drugs and anticoagulants and a comparison data from real clinical practice with current clinical guidelines are presented.
Keywords
atrial fibrillation,
survey,
antiarrhythmic drug therapy,
rhythm control,
rate control,
oral anticoagulants,
catheter ablation
Supporting agencies: This work partially was supported by the Ministry of Science and Higher Education grant (Russian Federation President Grant) #MD-2314.2020.7
About the Authors
Yu. V. Shubik
«Cardiology» clinical, scientific and educational centre of FSBEI HPE «Saint-Petersburg State University»
Russian Federation
Russian Federation
Yury Shubik
Saint-Petersburg, 7-9 Universitetskaya emb.
M. M. Medvedev
«Cardiology» clinical, scientific and educational centre of FSBEI HPE «Saint-Petersburg State University»
Russian Federation
Russian Federation
Saint-Petersburg, 7-9 Universitetskaya emb.
E. N. Mikhaylov
FSBI Almazov National Medical Research Centre
Russian Federation
Russian Federation
Saint-Petersburg, 2 Akkuratova str.
N. Z. Gasimova
FSBI Almazov National Medical Research Centre
Russian Federation
Russian Federation
Saint-Petersburg, 2 Akkuratova str.
M. Yu. Gilyarov
Pirogov Russian National Research Medical University; Pirogov City Clinical Hospital №1
Russian Federation
Russian Federation
Moscow, 1 Ostrovityanova str.
Moscow, 8 Leninsky ave.
References
1. Methodological Recommendation of Ministry of Health «Atrial fibrillation and flutter in adults», 2020. (In Russ.) http://cr.rosminzdrav.ru/#!/recomend/888.
2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2020; ehaa612. http://doi.org/10.1093/eurheartj/ehaa612.
3. Williams V. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24(4): 129-47. http://doi.org/10.1002/j.1552-4604.1984.tb01822.x.
4. Poole JE, Bahnson TD, Monahan KH, et al. recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J Am Coll Cardiol. 2020;75(25): 3105-3118. http://doi.org/10.1016/j.jacc.2020.04.065.
5. Packer DL, Kowal RC, Wheelan KR, et al. STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16): 1713-1723. http://doi.org/10.1016/j.jacc.2012.11.064.
6. Morillo CA, Verma A, Connolly SJ, et al. RAAFT-2 Investigators. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7): 692-700. http://doi.org/10.1001/jama.2014.467.
7. Marrouche NF, Brachmann J, Andresen D, et al. CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):17-427. http://doi.org/10.1056/NEJMoa1707855.
8. Dan G-A, Martinez-Rubio A, Agewall S, et al. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace. 2018;20(5): 731-732. http://doi.org/10.1093/europace/eux373.
9. Korobchenko LE, Bayramova SA, Kharats VE, et al. Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry. Russian Journal of Cardiology. 2020;25(5): 3874. (In Russ.)
10. Rychkov AYu, Khorkova NYu, Minulina AV. Trends in use of anticoagulants in patients with non-valvular atrial fibrillation. Journal of Arrhythmology. 2017;(87): 29-32. (In Russ.)
11. Shubik YuV. Features of the prevention of thromboembolic complications in patients with atrial fibrillation in Russia. Journal of Arrhythmology. 2017;(87): 5-6. (In Russ.)
Review
For citations:
Shubik Yu.V., Medvedev M.M., Mikhaylov E.N., Gasimova N.Z., Gilyarov M.Yu. Management of atrial fibrillation in Russia: real clinical practice and current clinical guidelines. Journal of Arrhythmology. 2021;28(2):55-63. (In Russ.) https://doi.org/10.35336/VA-2021-2-55-63
Views:
657
Email this article 